Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05925036 · ClinicalTrials.gov registry record · Phase 1
Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis
A Phase 1 study of Chronic Pain and Chronic Pancreatitis, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05925036: Recruiting Phase 1 study of Chronic Pain and Chronic Pancreatitis, sponsored by VA Office of Research and Development.
NCT05925036 is a Phase 1 study of Chronic Pain and Chronic Pancreatitis that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 40 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05925036, a Phase 1 study of Chronic Pain and Chronic Pancreatitis, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to test whether adult stem cells, called mesenchymal stem cells (MSCs) collected from the patient's bone marrow can help reduce pain caused by chronic pancreatitis and improve pancreatic function.
Primary Outcome
Change in pain as measured by Izbicki pain scores
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Mesenchymal stem cells
Study Locations (1)
South Carolina
- Ralph H. Johnson VA Medical Center, Charleston, SC - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2027-12-31 |
| Phase | Phase 1 |
What NCT05925036 shows while recruiting
NCT05925036 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05925036 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT05925036 about?
NCT05925036 is a clinical study titled "Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis". The goal of this clinical trial is to test whether adult stem cells, called mesenchymal stem cells (MSCs) collected from the patient's bone marrow can help reduce pain caused by chronic pancreatitis and improve pancreatic function.
What is the current status of trial NCT05925036?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2024-01-01. Estimated completion is 2027-12-31.
What conditions does trial NCT05925036 study?
This clinical trial studies the following conditions: Chronic Pain, Chronic Pancreatitis.
What interventions are being tested in trial NCT05925036?
The interventions under investigation include: Placebo (OTHER), Mesenchymal stem cells (DRUG).
Who is sponsoring clinical trial NCT05925036?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05925036 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05925036's enrollment target sits among peer trials
40 214th of 301 higher than 81 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Managing Chronic Tendon Pain by Metformin
RECRUITING · Phase 1
-
Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling
RECRUITING · Phase 1
-
ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain
RECRUITING · Phase 1
-
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
RECRUITING · Phase 1
-
Cognitive Behavioral Therapy for Insomnia in Chronic Pain Patients
COMPLETED · Phase 1
-
Development and Evaluation of Computerized Chemosensory Based Orbitofrontal Networks Training for Treatment of Pain
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI